Disease: T-cell lymphoma
- "Next top" mouse models advancing CTCL research
- A Case of Secondary Hemophagocytic Lymphohistiocytosis in a Patient With T-cell Lymphoma
- A Nomogram Model Based on the Inflammation-Immunity-Nutrition Score (IINS) and Classic Clinical Indicators for Predicting Prognosis in Extranodal Natural Killer/T-Cell Lymphoma
- A Rare Case of Extranodal Natural Killer/T-cell Lymphoma, Nasal Type Associated With Hemophagocytic Lymphohistiocytosis in a Patient With Recurrent Sinusitis
- A Rare Case of Methemoglobinemia after Ifosfamide Infusion in a 3-Year-Old Patient Treated for T-ALL
- A safety and efficacy study of allogeneic haematopoietic stem cell transplantation for refractory and relapsed T-cell acute lymphoblastic leukaemia/lymphoblastic lymphoma patients who achieved complete remission after autologous CD7 chimeric antigen recep
- A Unique Presentation of Peripheral T Cell Lymphoma: Diagnosis Behind the Deceiving Dry Tap
- Advancements in the Management of Follicular Lymphoma: A Comprehensive Review
- Alternating rabacfosadine and doxorubicin for treatment of naive canine lymphoma
- Analysis of mutation profiles in extranodal NK/T-cell lymphoma: clinical and prognostic correlations
- Analysis of the treatment and prognosis of 266 cases of extranodal natural killer/T-cell lymphoma, nasal type in a single medical center
- Antitumor Effect of Triptolide in T-Cell Lymphoblastic Lymphoma by Inhibiting Cell Viability, Invasion, and Epithelial-Mesenchymal Transition via Regulating the PI3K/AKT/mTOR Pathway [Retraction]
- Applied Cardio-Oncology in Hematological Malignancies: A Narrative Review
- Armored TGFβRIIDN ROR1-CAR T cells reject solid tumors and resist suppression by constitutively-expressed and treatment-induced TGFβ1
- Associations of granulocyte colony-stimulating factor with toxicities and efficacy of chimeric antigen receptor T-cell therapy in relapsed or refractory B-cell acute lymphoblastic leukemia
- BCL2A1 neoepitopes-elicited cytotoxic T lymphocytes are a promising individualized immunotherapy of pancreatic cancer
- Bilateral Cytomegalovirus Retinitis After Chimeric Antigen Receptor T-cell Therapy for B-cell Lymphoma
- CD58 alterations govern antitumor immune responses by inducing PD-L1 and IDO in diffuse large B-cell lymphoma
- Challenges in utilizing ALK expression to distinguish primary cutaneous from systemic anaplastic large cell lymphoma
- Cistanche phenylethanoid glycosides induce apoptosis and pyroptosis in T-cell lymphoma
- Clinical characteristics and prognostic analysis of primary extranodal non-Hodgkin lymphoma of the head and neck
- Clinical Efficacy of Programmed Cell Death Ligand 1 Antibody in Treatment of Extranodal Natural Killer/T-Cell Lymphoma With Hemophagocytic Lymphohistiocytosis
- Clinical Features of Non-Hodgkin Lymphoma-Associated Hemophagocytic Syndrome: a Retrospective Study
- Clinicopathologic analysis of nodal T-follicular helper cell lymphomas, a multicenter retrospective study from China
- Combination of chidamide and PD-1 blockade in Refractory/Relapsed aggressive large B-cell lymphomas with high risk of failing CAR-T therapy
- Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphoma
- Comparison of chemotherapy and chidamide combined with chemotherapy in patients with untreated angioimmunoblastic T-cell lymphoma
- Complete Rescue of HTLV-1<sub>p12KO</sub> Infectivity by Depletion of Monocytes Together with NK and CD8<sup>+</sup> T Cells
- Complete response to front-line therapies is associated with long-term survival in HIV-related lymphomas in Taiwan
- Comprehensive genetic profiling reveals frequent alterations of driver genes on the X chromosome in extranodal NK/T-cell lymphoma
- Conventional and novel [(18)F]FDG PET/CT features as predictors of CAR-T cell therapy outcome in large B-cell lymphoma
- Cost-effectiveness analysis 3L of axicabtagene ciloleucel vs tisagenlecleucel and lisocabtagene maraleucel in Japan
- Current and upcoming treatment approaches to uncommon subtypes of PTCL (EATL/MEITL, SPTCL, HSTCL)
- Cutaneous Intravascular Hematolymphoid Entities: A Review
- Cytokine signaling pathways as molecular markers of the efficacy of phototherapy in early stages of mycosis fungoides
- Daratumumab and venetoclax combined with CAGE for late R/R T-ALL/LBL patients: Single-arm, open-label, phase I study
- Diagnosis of bone marrow involvement in angioimmunoblastic T-cell lymphoma should be based on both [(18)F]FDG-PET/CT and bone marrow biopsy findings
- Discovery and preclinical development of a therapeutically active nanobody-based chimeric antigen receptor targeting human CD22
- Diverse and reprogrammable mechanisms of malignant cell transformation in lymphocytes: pathogenetic insights and translational implications
- Don't keep me waiting: estimating the lifetime impact of reduced vein-to-vein time for CAR-T treated patients with LBCL
- Early CAR(-) CD4(+) T-lymphocytes recovery following CAR-T cell infusion: A worse outcome in diffuse large B cell lymphoma
- Early evaluation of CAR-T cell therapy response in R/R DLBCL patients using (18)F-FDG PET/CT
- Effects of Cannabidiol, 9-Tetrahydrocannabinol, and WIN 55-212-22 on the Viability of Canine and Human Non-Hodgkin Lymphoma Cell Lines
- Efficacy and safety analysis of P-GemDOx regimen and stratified prognosis in patients with early extranodal NK/T cell lymphoma
- Efficacy of CAR T-Cell Therapy is Not Impaired by Previous Bispecific Antibody Treatment in Large B-Cell Lymphoma
- Efficacy of ruxolitinib in the treatment of relapsed/refractory large granular lymphocytic leukaemia
- Evolution of the clinical-stage hyperactive TcBuster transposase as a platform for robust non-viral production of adoptive cellular therapies
- Experience With Bexarotene to Treat Cutaneous T-Cell Lymphomas: A Study of the Spanish Working Group of Cutaneous Lymphomas
- FDG-PET/CT is a powerful tool to predict and evaluate response to chimeric antigen receptor (CAR) T-cell therapy in Non-Hodgkin-Lymphoma (NHL)
- FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy
- Granulocyte transfusion supportive care for prolonged cytopenias post CD19 CAR T cell therapy
- Hepatosplenic Alpha-Beta T-Cell Lymphoma: A Challenging Diagnostic Entity
- Hyperactive STAT5 hijacks T cell receptor signaling and drives immature T cell acute lymphoblastic leukemia
- Identification of a Patient Suitable for CAR-T Cell Therapy in the Outpatient Setting: A Vodcast and Case Example
- Immunotherapy of Hematological Malignancies of Human B-Cell Origin with CD19 CAR T Lymphocytes
- Infectious complications in pediatric patients undergoing CD19+CD22+ chimeric antigen receptor T-cell therapy for relapsed/refractory B-lymphoblastic leukemia
- InsT-ALLing CD7 chimeric antigen receptors before transplantation
- Intention-to-treat outcomes utilising a stringent event definition in children and young people treated with tisagenlecleucel for r/r ALL through a national access scheme
- Investigating Potential Cancer Therapeutics: Insight into Histone Deacetylases (HDACs) Inhibitions
- Investigating the safety and feasibility of osteopathic manipulative medicine in hospitalized children and adolescent young adults with cancer
- Management of relapsed/refractory mantle cell lymphoma
- Metabolic Profiling as an Approach to Differentiate T-Cell Acute Lymphoblastic Leukemia Cell Lines Belonging to the Same Genetic Subgroup
- Misdiagnosis of lymphoma as vasculitis: A case report
- Modulation of the skin microbiome in cutaneous T-cell lymphoma delays tumour growth and increases survival in the murine EL4 model
- Multi-omic profiling reveals the endogenous and neoplastic responses to immunotherapies in cutaneous T cell lymphoma
- Mycosis fungoides with large cell transformation (CD30+) and B-cell chronic lymphocytic leukemia
- Network meta-analysis of CAR T-Cell therapy for the treatment of 3L+ R/R LBCL after using published comparative studies
- New Insights into First-Line Therapy in Diffuse Large B-Cell Lymphoma: Are We Improving Outcomes?
- NK/T-cell lymphoma masquerading as penile chancre
- Novel agents and regimens in relapsed or refractory peripheral T-cell lymphoma: latest updates from 2023 ASH annual meeting
- Paediatric cutaneous lymphomas including rare subtypes: A 40-year experience at a tertiary referral centre
- Paediatric onset lymphomatoid papulosis: results of a multicentre retrospective cohort study, on behalf of the EORTC Cutaneous Lymphoma Tumours Group (CLTG)
- Patients with aggressive B-cell lymphoma receiving CAR T-cell therapy have a low rate of severe infections despite lack of universal antibacterial and antifungal prophylaxis
- Peripheral T-cell lymphomas expressing CD30 and CD15 expand the spectrum of anaplastic large cell lymphoma, ALK-negative
- Persistent Cytopenia After CD19 CAR T Therapy in Relapsed/Refractory DLBCL Patients Could Be a Predictor of Efficacy and Side Effects
- Post-infusion PD-1+CD8+CAR-T cells identify patients responsive to CD19-CAR-T therapy in non-Hodgkin's lymphoma
- Practical Aspects of Immunotherapy: A Report from the 20th International Myeloma Society (IMS) Annual Meeting
- Primary Central Nervous System Lymphoma, Treatment Outcomes - 10 Year Experience. Single Center Study
- Primary cutaneous anaplastic large-cell lymphoma resembling infratemporal space infection: a case report
- Primary pancreatic peripheral T-cell lymphoma: A case report
- Pyroptotic macrophages promote proliferation and chemotherapy resistance of peripheral T-cell lymphoma via TLR4 signaling pathway
- Real-World and Clinical Trial Outcomes in Large B-cell Lymphoma with Axicabtagene Ciloleucel Across Race and Ethnicity
- Real-world CAR-T findings for large B-cell lymphoma from a single institution experience
- Real-world patient characteristics, treatment patterns, and treatment outcomes of patients with diffuse large B-cell lymphoma by line of therapy
- Retrospective review of the toxicities and change in dosing patterns for pegaspargase in patients with acute lymphoblastic leukemia/lymphoma and T-cell lymphoma
- Safety and efficacy of a new academic CD19-directed CAR-T cell for refractory/relapsed non-Hodgkin lymphoma and acute lymphoblastic leukemia in Brazil
- Sequencing of anti-CD19 therapies in the management of diffuse large B-cell lymphoma
- Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis
- Single-cell T-cell receptor repertoire profiling in dogs
- SLC27A2 is a potential immune biomarker for hematological tumors and significantly regulates the cell cycle progression of diffuse large B-cell lymphoma
- Splenic Pseudoprogression After CAR-T Therapy Detected by 18F-FDG PET/CT in a Refractory Diffuse Large B-Cell Lymphoma Patient
- Staphylococcus aureus and Sézary syndrome
- Supportive care measures for bispecific T-cell engager therapies in haematological malignancies
- T-Cell Engagers-The Structure and Functional Principle and Application in Hematological Malignancies
- The dilemmas and possible solutions for CAR-T cell therapy application in solid tumors
- The Gut Connection: Exploring the Possibility of Implementing Gut Microbial Metabolites in Lymphoma Treatment
- The Role of Cytokines in Cutaneous T Cell Lymphoma: A Focus on the State of the Art and Possible Therapeutic Targets
- Unlocking adult T-cell leukemia/lymphoma's epigenetic secrets: delving into the mechanism and impact of EZH1/2 inhibition
- Upfront allogeneic hematopoietic stem cell transplantation for adult T-cell acute lymphoblastic leukemia/lymphoma in first complete remission: a single-center study
- XPO1 blockade with KPT-330 promotes apoptosis in cutaneous T-cell lymphoma by activating the p53-p21 and p27 pathways